Link Kowaltowski, A
Clinicians managing patients on testosterone who wish to explore retatrutide should: Consult the relevant clinical trial protocols if the patient is enrolled in a study Seek specialist endocrinology input before initiating any off-label or investigational combination Document clinical rationale clearly , obtain informed consent, and follow GMC Good Practice in Prescribing and Managing Medicines and Devices guidance when considering unlicensed or investigational treatments Until formal guidance is available, clinical decision-making should be guided by individual patient riskbenefit assessment, informed consent, and regular monitoring
Thinking about administration routes, dosing, monitoring, and cycling helps to tailor use to sperm production timelines and your personal health objectives
Trends in Endocrinology and Metabolism: TEM, 31, 410421
Any side effects are typically minor, such as slight redness or discomfort at the injection site
[see WARNINGS, DRUG ABUSE AND DEPENDENCE]